Last 7 days
-2.4%
Last 30 days
-20.4%
Last 90 days
-7.3%
Trailing 12 Months
-69.5%
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 54.3% | 7,448,000 | 4,828,000 | 3,548,000 | 3,483,000 | 2,963,000 |
Operating Expenses | -4.2% | 119,734,000 | 125,009,000 | 118,462,000 | 101,026,000 | 93,318,000 |
S&GA Expenses | -0.4% | 31,919,000 | 32,062,000 | 29,687,000 | 27,139,000 | 24,281,000 |
R&D Expenses | -5.5% | 87,815,000 | 92,947,000 | 88,775,000 | 73,887,000 | 69,037,000 |
EBITDA | -5.1% | -108,279,000 | -103,041,000 | -87,539,000 | -86,664,000 | - |
EBITDA Margin | 22.8% | -22.43 | -29.04 | -25.13 | -29.25 | - |
Earnings Before Taxes | 4.0% | -104,199,000 | -108,488,000 | -103,264,000 | -87,739,000 | -86,848,000 |
EBT Margin | 22.8% | -22.47 | -29.10 | -25.19 | -29.31 | - |
Net Income | 4.0% | -104,199,000 | -108,488,000 | -103,264,000 | -87,739,000 | -86,848,000 |
Net Income Margin | 22.8% | -22.47 | -29.10 | -25.19 | -29.31 | - |
Free Cahsflow | -17.0% | -103,382,000 | -88,390,000 | -107,790,000 | -68,190,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -2.1% | 672 | 686 | 720 | 752 | 776 |
Current Assets | -2.1% | 667 | 681 | 714 | 748 | 772 |
Cash Equivalents | -27.1% | 101 | 139 | 102 | 106 | 132 |
Net PPE | -0.9% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | -8.0% | 17.00 | 19.00 | 27.00 | 28.00 | 30.00 |
Current Liabilities | -6.1% | 13.00 | 14.00 | 21.00 | 21.00 | 17.00 |
Shareholder's Equity | -1.9% | 655 | 668 | 693 | 724 | 746 |
Retained Earnings | -8.5% | -267 | -246 | -218 | -184 | -162 |
Shares Outstanding | 0.1% | 219 | 218 | 218 | 218 | 218 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 7.0% | -96.10 | -103 | -88.43 | -78.36 | -68.19 |
Share Based Compensation | 15.5% | 16.00 | 14.00 | 14.00 | 11.00 | 9.00 |
Cashflow From Investing | 161.0% | 63.00 | -103 | -259 | -459 | -454 |
Cashflow From Financing | -9.0% | 1.00 | 1.00 | 1.00 | 5.00 | 626 |
81.6%
76.5%
65.4%
Y-axis is the maximum loss one would have experienced if Nuvation Bio was unfortunately bought at previous high price.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -0.05 | -5,177 | 29,823 | -% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | unchanged | - | -745 | 9,255 | -% |
2023-02-28 | Voya Investment Management LLC | unchanged | - | -14,356 | 88,644 | -% |
2023-02-21 | MACQUARIE GROUP LTD | sold off | - | -3,000 | - | -% |
2023-02-16 | AXXCESS WEALTH MANAGEMENT, LLC | sold off | -100 | -22,000 | - | -% |
2023-02-15 | ALLIANCEBERNSTEIN L.P. | added | 7.61 | -28,244 | 336,756 | -% |
2023-02-15 | Metropolitan Life Insurance Co/NY | unchanged | - | -2,552 | 14,448 | -% |
2023-02-15 | Virtu Financial LLC | new | - | 31,000 | 31,000 | -% |
2023-02-15 | Point72 Middle East FZE | new | - | 6,015 | 6,015 | -% |
2023-02-15 | JANE STREET GROUP, LLC | added | 0.53 | -48,604 | 303,396 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | deep track capital, lp | 3.76% | 8,221,188 | SC 13G/A | |
Feb 13, 2023 | blackrock inc. | 5.0% | 10,996,735 | SC 13G | |
Feb 13, 2023 | omega fund v, l.p. | 6.9% | 15,072,340 | SC 13D/A | |
Feb 09, 2023 | vanguard group inc | 4.55% | 9,932,441 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Jun 23, 2022 | deep track capital, lp | 5.26% | 11,471,281 | SC 13G | |
Feb 11, 2022 | castle creek arbitrage, llc | 10% | 215,426 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 19, 2021 | omega fund v, l.p. | 13.0% | 28,212,376 | SC 13D | |
Feb 19, 2021 | hung david | 27.4% | 59,645,012 | SC 13D |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 0.78 -52.44% | 0.79 -51.83% | 0.81 -50.61% | 0.85 -48.17% | 0.93 -43.29% |
Current Inflation | 0.78 -52.44% | 0.79 -51.83% | 0.81 -50.61% | 0.84 -48.78% | 0.91 -44.51% |
Very High Inflation | 0.78 -52.44% | 0.79 -51.83% | 0.80 -51.22% | 0.83 -49.39% | 0.88 -46.34% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 16, 2023 | S-8 | Employee Benefits Plan | |
Mar 15, 2023 | 10-K | Annual Report | |
Mar 15, 2023 | 8-K | Current Report | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2022-12-05 | FALBERG KATHRYN E | bought | 83,961 | 1.9526 | 43,000 | - |
2022-12-02 | FALBERG KATHRYN E | bought | 93,186 | 1.9827 | 47,000 | - |
2022-12-01 | FALBERG KATHRYN E | bought | 167,599 | 1.9727 | 84,959 | - |
2022-11-30 | FALBERG KATHRYN E | bought | 139,088 | 1.8535 | 75,041 | - |
2022-04-05 | Omega Fund V, L.P. | sold | -14,000,000 | 5.6 | -2,500,000 | - |
2021-12-15 | Omega Fund V, L.P. | sold | -5,035,000 | 10.07 | -500,000 | - |
2021-12-07 | Omega Fund V, L.P. | sold | -13,720,000 | 9.8 | -1,400,000 | - |
2021-11-24 | NODELMAN OLEG | bought | 1,254,860 | 7.6859 | 163,268 | - |
2021-11-24 | NODELMAN OLEG | bought | 167,230 | 7.6859 | 21,758 | - |
2021-11-23 | Omega Fund V, L.P. | sold | -351 | 9.75 | -36.00 | - |
Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | |
Operating expenses: | ||
Research and development | $ 87,815 | $ 69,037 |
General and administrative | 31,919 | 24,281 |
Total operating expenses | 119,734 | 93,318 |
Loss from operations | (119,734) | (93,318) |
Other income (expense): | ||
Interest income | 7,448 | 2,963 |
Investment advisory fees | (872) | (644) |
Change in fair value of warrants liability | 10,187 | 4,231 |
Net (loss) gain on marketable securities | (1,228) | (80) |
Total other income (expense), net | 15,535 | 6,470 |
Loss before income taxes | (104,199) | (86,848) |
Provision for income taxes | 0 | 0 |
Net loss | $ (104,199) | $ (86,848) |
Net loss per share attributable to common stockholders, basic | $ (0.48) | $ (0.44) |
Net loss per share attributable to common stockholders, diluted | $ (0.48) | $ (0.44) |
Weighted average common shares outstanding, basic | 216,721 | 197,887 |
Weighted average common shares outstanding, diluted | 216,721 | 197,887 |
Comprehensive loss: | ||
Net loss | $ (104,199) | $ (86,848) |
Other comprehensive income (loss), net of taxes: | ||
Unrealized loss on available-for-sale securities, net | (4,341) | (2,742) |
Comprehensive loss | $ (108,540) | $ (89,590) |
Consolidated Balance Sheet - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets | ||
Cash equivalents | $ 101,099 | $ 132,423 |
Prepaid expenses and other current assets | 3,819 | 3,642 |
Marketable securities | 559,915 | 632,969 |
Interest receivable on marketable securities | 2,485 | 3,039 |
Total Current Assets | 667,318 | 772,073 |
Property and equipment, net | 894 | 786 |
Lease security deposit | 138 | 421 |
Right of use asset | 3,791 | 2,871 |
Total Assets | 672,141 | 776,151 |
Current liabilities | ||
Accounts payable | 2,139 | 3,925 |
Current operating lease liabilities | 1,206 | 863 |
Accrued expenses | 9,816 | 12,137 |
Total Current Liabilities | 13,161 | 16,925 |
Warrant Liability | 850 | 11,037 |
Non-current operating lease liabilities | 3,054 | 2,192 |
Total Liabilities | 17,065 | 30,154 |
Commitments and contingencies | ||
Stockholders' Equity | ||
Class A and Class B common stock and additional paid in capital, $0.0001 par value per share; 1,060,000,000 (Class A 1,000,000,000,Class B 60,000,000) and 1,174,094,678 (Class A 880,000,000, Class B 294,094,678) shares authorized as of December 31, 2021 and December 31, 2020, respectively, 217,948,568 (Class A 216,948,568, Class B 1,000,000) and 149,042,155 (Class A 91,397,142, Class B 57,645,013) shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively | 927,604 | 909,985 |
Accumulated deficit | (267,002) | (162,803) |
Accumulated other comprehensive (loss) income | (5,526) | (1,185) |
Total Stockholders' Equity | 655,076 | 745,997 |
Total Liabilities and Stockholders' Equity | $ 672,141 | $ 776,151 |